Abnormal peripheral lymphocyte function in c-abl mutant mice

被引:35
作者
Hardin, JD
Boast, S
Schwartzberg, PL
Lee, G
Alt, FW
Stall, AM
Goff, SP
机构
[1] COLUMBIA UNIV, COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA
[2] COLUMBIA UNIV, COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA
[3] HOWARD HUGHES MED INST, BOSTON, MA 02115 USA
关键词
D O I
10.1006/cimm.1996.0220
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The proto-oncogene c-abl encodes a tyrosine kinase that is hypothesized to function in proliferation-stimulatory signaling pathways. Previous work on mice homozygous for targeted mutations in the c-abl gene (abl(m1) and abl(2) mutant strains) has demonstrated multiple defects, including a susceptibility to infections that results in a high mortality rate after weaning. FAGS analysis of the hemopoietic system of c-abl mutants demonstrated variable reductions in B and T lymphocytes in adult bone marrow, thymus, spleen, and peripheral blood, In addition, bone marrow from mutants showed a decreased ability to respond to interleukin-7. We further found that B cells from abl(ml) mice had a reduced ability to respond to lipopolysaccharide (decreased to 10% of control response) that was dependent on the culture conditions and the tissue of origin of B cells. Peripheral blood from the mutants also had a reduced response to the T cell mitogen concanavalin A, Immune response in abl(m1) mice as determined by the mixed lymphocyte response and the sheep red blood cell plaque-forming assay was grossly normal. These findings suggest that although specific signaling pathways in lymphocytes may involve c-Abl, the immune system can function in the absence of a normal c-abl gene product. (C) 1996 Academic Press, Inc.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 54 条
  • [1] ALTERNATIVE 5' EXONS IN C-ABL MESSENGER-RNA
    BEN-NERIAH, Y
    BERNARDS, A
    PASKIND, M
    DALEY, GQ
    BALTIMORE, D
    [J]. CELL, 1986, 44 (04) : 577 - 586
  • [2] EXPRESSION OF C-SRC AND C-ABL IN EMBRYONAL CARCINOMA-CELLS AND ADULT-MOUSE TISSUES
    BOULTER, CA
    WAGNER, EF
    [J]. EXPERIMENTAL CELL RESEARCH, 1988, 179 (01) : 214 - 221
  • [3] BUCALA R, 1992, IMMUNOLOGY, V77, P477
  • [4] UNIQUE FORMS OF THE ABL TYROSINE KINASE DISTINGUISH PH1-POSITIVE CML FROM PH1-POSITIVE ALL
    CLARK, SS
    MCLAUGHLIN, J
    CRIST, WM
    CHAMPLIN, R
    WITTE, ON
    [J]. SCIENCE, 1987, 235 (4784) : 85 - 88
  • [5] Coligan JE, 1992, CURRENT PROTOCOLS IM
  • [6] CUNNINGHAM AJ, 1968, IMMUNOLOGY, V14, P599
  • [7] DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143
  • [8] REGULATION OF B-CELL DIFFERENTIATION BY BONE-MARROW STROMAL CELLS
    DORSHKIND, K
    LANDRETH, KS
    [J]. INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 (01): : 12 - 17
  • [9] THE POLYCLONAL LIPOPOLYSACCHARIDE RESPONSE IS ACCESSORY-CELL-DEPENDENT
    FERNANDEZ, C
    SEVERINSON, E
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1983, 18 (04) : 279 - 289
  • [10] DELETION OF AN N-TERMINAL REGULATORY DOMAIN OF THE C-ABL TYROSINE KINASE ACTIVATES ITS ONCOGENIC POTENTIAL
    FRANZ, WM
    BERGER, P
    WANG, JYJ
    [J]. EMBO JOURNAL, 1989, 8 (01) : 137 - 147